These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8752025)

  • 1. Breakthrough panic after amantadine treatment in a Parkinson's disease patient.
    Noveske FG
    J Clin Psychiatry; 1996 Aug; 57(8):374. PubMed ID: 8752025
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Parkinson's disease with amantadine (Symmetrel).
    van Manen J
    Psychiatr Neurol Neurochir; 1972; 75(1):49-59. PubMed ID: 5024896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
    De la Herrán J; Figuerido JA
    Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amantadine in the treatment of Parkinson's disease].
    Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
    Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of panic disorder with bupropion in a patient with Parkinson's disease.
    Gebhardt S; Röttgers H; Bäcker A; Schu U; Krieg JC
    J Clin Pharm Ther; 2008 Oct; 33(5):575-7. PubMed ID: 18834374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences with amantadine hydrochloride in Parkinson's disease.
    Griffiths AV; Parker WN; Palmer RM
    Practitioner; 1971 Nov; 207(241):679-80. PubMed ID: 5134819
    [No Abstract]   [Full Text] [Related]  

  • 9. Amantadine in Parkinson's disease: pro and contra.
    Greulich W; Fenger E
    J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 11. Renaissance of amantadine in the treatment of Parkinson's disease.
    Blanchet PJ; Metman LV; Chase TN
    Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced delusions of parasitosis during treatment of Parkinson's disease.
    Swick BL; Walling HW
    J Am Acad Dermatol; 2005 Dec; 53(6):1086-7. PubMed ID: 16310077
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden bilateral corneal oedema in a patient with Parkinson's disease.
    Park CY; Chuck RS
    Acta Ophthalmol; 2011 Mar; 89(2):198-9. PubMed ID: 19604157
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety.
    Richard IH; Szegethy E; Lichter D; Schiffer RB; Kurlan R
    Clin Neuropharmacol; 1999; 22(3):172-5. PubMed ID: 10367182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"].
    Völler G
    Munch Med Wochenschr; 1972 Jun; 114(22):1066-7. PubMed ID: 5068022
    [No Abstract]   [Full Text] [Related]  

  • 16. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
    Singer C; Papapetropoulos S; Gonzalez MA; Roberts EL; Lieberman A
    Mov Disord; 2005 Jul; 20(7):873-7. PubMed ID: 15809995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
    Silver DE; Sahs AL
    Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle].
    Fünfgeld EW
    Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Nil nocere." Side effects during treatment of Parkinson's disease with amantadine].
    Diehl LW
    Munch Med Wochenschr; 1972 Mar; 114(10):445-7. PubMed ID: 4625982
    [No Abstract]   [Full Text] [Related]  

  • 20. Amantadine-induced livedo reticularis: a report of two cases.
    Hayes BB; Cook-Norris RH; Miller JL; Rodriguez A; Zic JA
    J Drugs Dermatol; 2006 Mar; 5(3):288-9. PubMed ID: 16573266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.